OrHal®, the first partitioned mask for inhalation chambers or nebulization, designed by the OptimHal laboratory’s research team in 2015, got the issuance of its European patent on August 19, 2020
OrHal® inhalation mask : a very innovative medical device that improves the effectiveness of aerosol treatments
OrHal® mask has been designed to optimize the intake of inhaled treatment by avoiding aerosolized drugs to be trapped by the nose.
Thanks to its flexible and sealed wall between the nose and the mouth, OrHal® avoids nasal inhalation and favors oral inhalation. This helps preventing a large portion of the medicine from being caught by the nasal cilia and mucus and so, improves the pulmonary deposition of aerosolized medicines.
Marketed since 2017 with TipsHaler® inhalation chamber, OrHal® mask is available in pediatric or adult versions and in nebulization version.
The granting of this European patent is a real recognition of the innovative design of this device which significantly improves the performance of inhalation devices.